SEC Form 4 · accession 0001070081-17-000086
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Shane William Charles Kovacs
Officer — Chief Financial Officer
Period of report
May 9, 2017
Accepted (ET)
May 11, 2017 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 9, 2017 | M | 10,000 | $10.85 | A | 37,850 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right To Buy)F1 | $10.85 | May 9, 2017 | M | 10,000 | D | — | May 21, 2023 | Common Stock | 10,000 | 45,625 | D |
| Stock Option (Right To Buy)F2 | $27.05 | holding | — | — | — | — | Jan 27, 2024 | Common Stock | 46,384 | 46,384 | D |
| Stock Option (Right To Buy)F3 | $51.00 | holding | — | — | — | — | Jan 1, 2025 | Common Stock | 85,600 | 85,600 | D |
| Stock Option (Right To Buy)F4 | $30.86 | holding | — | — | — | — | Jan 3, 2026 | Common Stock | 80,000 | 80,000 | D |
| Stock Option (Right To Buy)F5 | $11.23 | holding | — | — | — | — | Jan 2, 2027 | Common Stock | 52,500 | 52,500 | D |
Explanation of responses
- F1This option award was granted on May 22, 2013, with 25% of the shares underlying the option vested on May 22, 2014, and an additional 2.083% of the original number of shares underlying the option vesting on a monthly basis thereafter, beginning on June 30, 2014.
- F2This option award was granted on January 28, 2014, with 25% of the shares underlying the option vested on January 1, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2015.
- F3This option award was granted on January 2, 2015, with 25% of the shares underlying the option vesting on January 1, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 1, 2016.
- F4This option was granted on January 4, 2016, and vests over four years, with 25% of the shares underlying the option vesting on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
- F5This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.